Search
for
Sort by
Research 121–150 of 309
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population
- Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- 52993 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Alopecia Areata: An Updated Review for 2023
- Correlation of trichoscopic findings with clinico-epidemiological factors in male pattern&nbsp;<span style="font-size: 1rem;">hairloss: A cross-sectional study from a tertiary care center in Chengalpattu</span>
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Phytochemicals and novel delivery systems in alopecia management: An integrative review
- Hair Disorders in Autoimmune Diseases
- Scalp Microinfusion: A Novel Drug Delivery Technique for Hair Loss Treatment
- Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions